Senolytic Therapeutics

About:

Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells.

Website: http://senolytx.com/

Top Investors: EASME - EU Executive Agency for SMEs

Description:

Senolytic Therapeutics is a operator of a pharmaceutical company intended to develop medicines and therapeutics for patients affected by age-related diseases. The company's medicines target and eliminate damaged cells, enabling healthcare providers to improve the lives of those affected by diseases associated with aging.

Total Funding Amount:

$583000

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2017-01-01

Founders:

Marc Ramis Castelltort

Number of Employees:

1-10

Last Funding Date:

2018-08-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai